Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Belantamab
Trade Name
Synonyms GSK2857914|GSK-2857914|GSK 2857914
Drug Descriptions

Belantamab is a monoclonal antibody targeting TNFRSF17 (BCMA), which potentially decreases tumor growth (PMID: 34253590).

DrugClasses TNFRSF17 Antibody 18
CAS Registry Number 2061894-48-0
NCIT ID C171828


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Belantamab Belantamab 0 1
Belantamab + belantamab mafodotin-blmf + Dexamethasone + Lenalidomide Belantamab Dexamethasone Lenalidomide belantamab mafodotin-blmf 0 1

Additional content available in CKB BOOST